$MFST Today, Medifirst President Bruce J. Schoengood, stated that “CDB products are a great complement to our FDA cleared Time Machine Therapeutic Laser for all natural pain relief, and there is a tremendous demand for CBD products. Through our existing healthcare relationships, we have strong interest from oversea markets for China, Japan, and the Asia-Pacific region as well as in the U. S. market. Medifirst is working on completing related contracts and agreements and anticipates a formal announcement in the upcoming days and weeks.” https://globenewswire.com/news-release/2018/10/29/1638573/0/en/Medifirst-Solutions-Announces-New-Division-for-CBD-Products.html
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.